Literature DB >> 173827

The occurrence of hepatoma in the chronic form of hereditary tyrosinemia.

A G Weinberg, C E Mize, H G Worthen.   

Abstract

A 5 1/2-year-old child with hepatocarcinoma complicating hereditary tyrosinemia is presented. A review of the literature and an attempted follow-up of previously reported patients with the chronic form of hereditary tyrosinemia have disclosed 16 cases of hepatocarcinoma occurring in 43 patients surviving beyond 2 years of age (37%). This incidence is considerably higher than that generally given for the occurrence of hepatoma in adults with macronodular cirrhosis. Females and males are equally at risk. Additional factors beyond the development of cirrhosis are likely operative in the induction of hepatocarcinoma in patients with this metabolic disorder; those surviving beyond infancy are at considerable risk for the development of fatal hepatic neoplasms.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 173827     DOI: 10.1016/s0022-3476(76)80259-4

Source DB:  PubMed          Journal:  J Pediatr        ISSN: 0022-3476            Impact factor:   4.406


  59 in total

1.  Type I hereditary tyrosinaemia: presentation of 11 cases.

Authors:  T Coşkun; I Ozalp; N Koçak; A Yüce; M Caglar; R Berger
Journal:  J Inherit Metab Dis       Date:  1991       Impact factor: 4.982

2.  Renal function in tyrosinaemia type I after liver transplantation: a long-term follow-up.

Authors:  L J W M Pierik; F J van Spronsen; C M A Bijleveld; C M L van Dael
Journal:  J Inherit Metab Dis       Date:  2005       Impact factor: 4.982

3.  Liver transplantation in a 23-year-old tyrosinaemia patient: effects on the renal tubular dysfunction.

Authors:  E A Kvittingen; E Jellum; O Stokke; A Flatmark; A Bergan; G Sødal; S Halvorsen; E Schrumpf; E Gjone
Journal:  J Inherit Metab Dis       Date:  1986       Impact factor: 4.982

4.  Epidemiology and carcinogenesis of hepatocellular carcinoma.

Authors:  Trishe Y-M Leong; Anthony S-Y Leong
Journal:  HPB (Oxford)       Date:  2005       Impact factor: 3.647

5.  Liver transplantation for hereditary tyrosinemia: the Quebec experience.

Authors:  K Paradis; A Weber; E G Seidman; J Larochelle; L Garel; C Lenaerts; C C Roy
Journal:  Am J Hum Genet       Date:  1990-08       Impact factor: 11.025

6.  Liver transplantation for hereditary tyrosinemia in the presence of hepatocellular carcinoma.

Authors:  C O Esquivel; L Mieles; I R Marino; S Todo; L Makowka; G Ambrosino; P Nakazato; T E Starzl
Journal:  Transplant Proc       Date:  1989-02       Impact factor: 1.066

Review 7.  Tyrosinaemia type I: orthotopic liver transplantation as the only definitive answer to a metabolic as well as an oncological problem.

Authors:  F J van Spronsen; R Berger; G P Smit; J B de Klerk; M Duran; C M Bijleveld; H van Faassen; M J Slooff; H S Heymans
Journal:  J Inherit Metab Dis       Date:  1989       Impact factor: 4.982

8.  A syndrome of hereditary tyrosinemia in mink (Mustela vison Schreb.).

Authors:  K Christensen; P Fischer; K E Knudsen; S Larsen; H Sørensen; O Venge
Journal:  Can J Comp Med       Date:  1979-07

Review 9.  Tyrosinaemia type I and NTBC (2-(2-nitro-4-trifluoromethylbenzoyl)-1,3-cyclohexanedione).

Authors:  E Holme; S Lindstedt
Journal:  J Inherit Metab Dis       Date:  1998-08       Impact factor: 4.982

10.  Pancreatic adenocarcinoma in type 2 progressive familial intrahepatic cholestasis.

Authors:  Lee M Bass; Deepa Patil; M Sambasiva Rao; Richard M Green; Peter F Whitington
Journal:  BMC Gastroenterol       Date:  2010-03-13       Impact factor: 3.067

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.